Life Science Innovators Partner to Transform the Samples-to-Insight Cycle SAN DIEGO , Sept. 19, 2024 /PRNewswire/ -- CS Genetics , an innovative genomics technology company, today announced a strategic partnership with ROSALIND® , the premier SaaS platform empowering life science research across diverse technologies. By combining the wet-bench simplicity of CS Genetics' SimpleCellTM platform with ROSALIND®'s multi-omics analysis, this partnership will help researchers significantly expand their single-cell capabilities.
The integrated solution will unlock insights faster and more efficiently, empowering scientists to drive breakthrough discoveries at a fraction of the traditional cost. "At CS Genetics, we've developed the SimpleCellTM platform to redefine the economics of single-cell genomics, removing the need for expensive instruments and slashing per-sample costs," said Jay Harger , Chief Operating Officer at CS Genetics. "By partnering with ROSALIND®, we're enabling biopharma and academic teams to run much larger, more rigorous single-cell projects while accessing best-in-class analysis and collaboration tools.
" The CS Genetics solution introduces a unique instrument-free, solution-phase platform powered by Kinetic Confinement, that delivers unprecedented simplicity and scalability. With its ability to integrate into standard lab workflows at lower costs, both biopharma and academic researchers can now conduct larger single-cell studies, generating critical insights wi.